Index. Note: Page numbers of article titles are in boldface type.

Size: px
Start display at page:

Download "Index. Note: Page numbers of article titles are in boldface type."

Transcription

1 Index Note: Page numbers of article titles are in boldface type. A Abatacept, for rheumatoid arthritis, 789 Acetaminophen, for low back pain, 735 Acupuncture for fibromyalgia, 753 for low back pain, 738 Adalimumab for rheumatoid arthritis, 789 monitoring of, Adrenocorticotropin, for gout, 707 Allopurinol, for gout, Alternative therapies, for fibromyalgia, 752 Amaurosis fugax, in temporal arteritis, 759 Amitriptyline, for fibromyalgia, 749 Analgesics, for fibromyalgia, 750 Aneurysms, in temporal arteritis, 765 Ankylosing spondylitis, treatment of, 725 Antibiotics, for infectious arthritis, Anticonvulsants, for fibromyalgia, 750 Anticyclic citrullinated peptide antibody, 680, 684, 784 Antidepressants for fibromyalgia, 749 Antinuclear antibodies, 681, , Antiphospholipid antibodies, in SLE, 775 Aortic aneurysm, in temporal arteritis, 765 Arteritis, temporal. See Temporal arteritis. Arthritis classification of, 714 degenerative (osteoarthritis), injection therapy for, in SLE, , 772 in temporal arteritis, inflammatory. See Inflammatory arthritis. psoriatic, 725 rheumatoid. See Rheumatoid arthritis. with effusion aspiration of. See Arthrocentesis. differential diagnosis of, 692 injection of. See Injection, joint. Arthrocentesis, 677, 682, complications of, 692, Prim Care Clin Office Pract 37 (2010) doi: /s (10) primarycare.theclinics.com /10/$ see front matter ª 2010 Elsevier Inc. All rights reserved.

2 806 Index Arthrocentesis (continued) contraindications to, 692 for rheumatoid arthritis, 784 indications for, 691 of elbow, 700 of knee, 698 of shoulder, synovial fluid analysis and, technique for, Aspiration, joint. See Arthrocentesis. Aspirin, in temporal arteritis, 763 Azathioprine for SLE, 774 for temporal arteritis, 765 monitoring of, , 801 B Back pain, low. See Low back pain. Balineotherapy, for fibromyalgia, 753 Benzbromarone, for gout, 708 Biofeedback therapy, for fibromyalgia, 753 Biologic response modifiers, for noninfectious arthritis, Biopsy, of temporal artery, Blindness, in temporal arteritis, 759 Bone scan, for infectious arthritis, C Cancer, surveillance for, 795 Cardiovascular disease, surveillance for, 794 Cauda equina syndrome, treatment of, 735 Ceftriaxone, for infectious arthritis, 720 Celecoxib for gout, 707 for rheumatoid arthritis, Cellular immune response, in temporal arteritis, 758 Chiropractor treatment, for low back pain, 738 Chlamydial arthritis, 720 Chronic fatigue syndrome, Ciprofloxacin, for infectious arthritis, 720 Cirrhosis, methotrexate-induced, 800 Claudication, in temporal arteritis, , 762 Cognitive behavioral therapy, for fibromyalgia, Colchicine, for gout, Color duplex ultrasonography, for temporal arteritis, 761 Complete blood cell count, 678, 761 Computed tomography, for low back pain, 734 Corticosteroids for gout,

3 Index 807 for noninfectious arthritis, 724 for psoriatic arthritis, 715 for rheumatoid arthritis, for SLE, for temporal arteritis, injection of, 695 complications of, preparations for, 696 technique for, monitoring of, , Cough, in temporal arteritis, 759 C-reactive protein, 679, 761 Crystal(s), in synovial fluid, 694. See also Gout. Culture, of synovial fluid, Cyclobenzaprine for fibromyalgia, 749 monitoring of, 802 Cyclooxygenase-2 inhibitors, for rheumatoid arthritis, Cyclophosphamide, monitoring of, 796, 798 Cyclosporine, monitoring of, , Cytology, synovial fluid, 694 D Dermatitis, gold salt-induced, Desipramine, for fibromyalgia, 749 Diplopia, in temporal arteritis, 759 Disc herniation, pain in, Disease-modifying antirheumatic drugs for noninfectious arthritis, for rheumatoid arthritis, monitoring of, tuberculosis surveillance with, 799 DMARDs. See Disease-modifying antirheumatic drugs. Doxycycline, for infectious arthritis, 720 Duloxetine, for fibromyalgia, E Education, for fibromyalgia, 752 Effusions, joint, inspection and analysis of, Elbow, arthrodesis and injection of, 700 Elderly persons, rheumatoid arthritis in, 786 Erythrocyte sedimentation rate, 679, Etanercept for rheumatoid arthritis, 789 monitoring of, Exercise for fibromyalgia, 751 for low back pain, 737

4 808 Index F Fatigue, in fibromyalgia, 744 Febuxostat, for gout, 707, 709 Fever, in temporal arteritis, 759 Fibromyalgia, clinical features of, 744 definition of, 743 diagnosis of, differential diagnosis of, 747 epidemiology of, pathophysiology of, 744 prognosis for, 753 risk factors for, 745 treatment of, Fluorescent antinuclear antibody test, for SLE, Fluoxetine, for fibromyalgia, 749 G Gabapentin for fibromyalgia, 749 Gastrointestinal disorders hydroxychloroquine-induced, 799 mycophenolate-induced, 799 NSAID-induced, Genetic factors, in rheumatoid arthritis, 780 Giant cell arteritis. See Temporal arteritis. Glomerulonephritis, in SLE, Glucocorticoids. See Corticosteroids. Gold therapy, monitoring of, , Gonococcal arthritis, Gout, clinical presentation of, diagnosis of, 705 differential diagnosis of, 705 epidemiology of, 704 pathophysiology of, treatment of, Gram stain for infectious arthritis, 720 of synovial fluid, H Headache in fibromyalgia, 744 in temporal arteritis, , 762 Hearing loss, in temporal arteritis, 759 Hematuria, gold salt-induced, Heparin, for antiphospholipid antibody syndrome, 775

5 Index 809 Hodgkin s lymphoma, surveillance for, 795 Hyaluronic acid derivatives, injection of, for osteoarthritis, Hydroxychloroquine for rheumatoid arthritis, 787, for SLE, monitoring of, Hyperuricemia, in gout, Hypnotherapy, for fibromyalgia, 753 I Indomethacin, for reactive arthritis, 715 Infections cyclophosphamide-induced, 802 in rheumatoid arthritis, 790 temporal arteritis in, 758 triggering rheumatoid arthritis, 780 Inflammatory arthritis, classification of, 714 infectious diagnosis of, pathogenesis of, treatment of, noninfectious, classification of, 721 diagnosis of, treatment of, referral for, Inflammatory bowel disease, arthritis in, 725 Inflammatory mediators, in rheumatoid arthritis, Infliximab for rheumatoid arthritis, 789 for temporal arteritis, monitoring of, Injection, joint complications of, contraindications for, 695 corticosteroid preparations for, 696 indications for, of elbow, 700 of knee, 698 of shoulder, technique for, Ischemia, in temporal arteritis, 758 J Jaw claudication, in temporal arteritis, 759, 762 Joint(s) aspiration of. See Arthrocentesis. injection of. See Injection, joint. Juvenile rheumatoid arthritis,

6 810 Index K Kidney disorders cyclosporine-induced, gold salt-induced, in SLE, NSAID-induced, 803 surveillance for, 794 tacrolimus-induced, Kineret, monitoring of, Knee, arthrodesis and injection of, 698 L Laboratory testing, anti-cyclic citrullinated peptide antibody, 680, 684 antinuclear antibodies, 681, arthrocentesis for, 677, 682 complete blood cell count, 678 C-reactive protein, 679, 761 diagnostic investigations for, erythrocyte sedimentation rate, 679, history taking before, , 682 physical examination before, 675, 682 radiography for, , 683 rheumatoid factor, , 684 sensitivity and specificity of, uric acid, 678, 684 Leflunomide for rheumatoid arthritis, 789 for SLE, 774 monitoring of, Leukemia, surveillance for, 795 Leukopenia, sulfasalazine-induced, 799 Liver disease, methotrexate-induced, 800 Low back pain, definition of, 729 diagnosis of, differential diagnosis of, economic cost of, 729 red flags in, treatment of, yellow flags in, Lumbar pain. See Low back pain. Lupus. See Systemic lupus erythematosus. Lyme disease, laboratory tests for, 686 Lymphoma, surveillance for, 795 M Magnetic resonance imaging for infectious arthritis, for low back pain, 734

7 Index 811 Malar rash, in SLE, Manipulation therapy, for low back pain, 738 Meditation, for fibromyalgia, 753 Methotrexate for rheumatoid arthritis, 787, for SLE, 774 for temporal arteritis, 764 monitoring of, , 800 Milnacipran, for fibromyalgia, 750 Minocycline for rheumatoid arthritis, 787, 789 monitoring of, Multiple myeloma, surveillance for, 795 Muscle relaxants, for low back pain, Mycophenolate mofetil for SLE, 774 monitoring of, 802 Myelosuppression azathioprine-induced, 801 methotrexate-induced, 800 Myofascial pain syndrome, N Neonatal lupus, 775 Nephritis, in SLE, Neurologic disorders cyclorsporine-induced, in low back pain, in temporal arteritis, 759 tacrolimus-induced, Nonsteroidal antiinflammatory drugs, for gout, for low back pain, for noninfectious arthritis, 724 for psoriatic arthritis, 715 for reactive arthritis, 715 for SLE, 772 monitoring of, , O Opiates for fibromyalgia, Osteoarthritis, injection therapy for, Osteoporosis in corticosteroid therapy, surveillance for, 794 Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERTA), 793

8 812 Index P Pain in fibromyalgia, 744, in gout, 705 in rheumatoid arthritis, 783 in SLE, low back. See Low back pain. Pancytopenia, gold salt-induced, 801 Paroxetine, for fibromyalgia, 749 Pediatric patients, rheumatoid arthritis in, Physical therapy, for low back pain, 738 Pneumonitis gold salt-induced, 801 methotrexate-induced, 800 Polymyalgia rheumatica, , 758 Postinfectious arthritis, treatment of, 725 Postinjection flare, in joint injection, Predictive values, of laboratory tests, Prednisolone, for gout, Prednisone for rheumatoid arthritis, for SLE, Pregabalin for fibromyalgia, Pregnancy, SLE and, 775 Probenecid, for gout, Proteinuria, gold salt-induced, Psoriatic arthritis, treatment of, 725 R Radiography, , 683 for infectious arthritis, 717 for low back pain, 734 for rheumatoid arthritis, 784 Rasburicase, for gout, 707, 709 Reactive arthritis, treatment of, 725 Remitting seronegative symmetric synovitis with pitting edema syndrome, Respiratory symptoms, in temporal arteritis, 759 Retinopathy, hydroxychloroquine-induced, 772, 799 Rheumatoid arthritis, cancer in, 795 cardiovascular disease in, 794 corticosteroid injections for, 695 diagnosis of, differential diagnosis of, duration of, 789 elderly onset, 786 epidemiology of,

9 Index 813 extra-articular symptoms of, 784 juvenile, kidney disease in, 794 laboratory tests for, osteoporosis in, 794 pathophysiology of, risk factors for, 780 symptoms of, treatment of, , Rheumatoid factor, , 684, 783 Rheumatology arthrocentesis for, crystal arthropathies, disease incidence, 681 fibromyalgia, inflammatory arthropathies, joint injection, laboratory testing in, low back pain, nonrheumatologic diseases and, rheumatoid arthritis. See Rheumatoid arthritis. systemic lupus erythematosus. See Systemic lupus erythematosus. temporal arteritis, Rituximab, for rheumatoid arthritis, 789 S Selective serotonin reuptake inhibitors, for fibromyalgia, 749 Septic arthritis. See Inflammatory arthritis, infectious. Septicemia, arthrocentesis in, 692 Serotonin-norepinephrine reuptake inhibitors, for fibromyalgia, Shoulder, arthrodesis and injection of, Skin disorders, in SLE, SLE. See Systemic lupus erythematosus. Sleep disorders, in fibromyalgia, 752 Spinal manipulation, for low back pain, 738 Statins, for rheumatoid arthritis, 790 Stiffness in fibromyalgia, 744 in rheumatoid arthritis, 783 Stomatitis, gold salt-induced, Straight leg raise test, for disc herniation, 733 Stress, fibromyalgia and, 745 Stroke, in temporal arteritis, 759 Sulfasalazine for reactive arthritis, 715 for rheumatoid arthritis, 787, monitoring of, Synovial fluid aspiration of. See Arthrocentesis. crystal detection in, 694

10 814 Index Synovial (continued) culture of, cytology of, 694 Gram stain of, inspection of, 693 laboratory analysis of, 693 for infectious arthritis, 717 for noninfectious arthritis, 723 for rheumatoid arthritis, 784 Synovium autoimmune response in, in rheumatoid arthritis, biopsy of, in infectious arthritis, 717 Systemic lupus erythematosus, antiphospholipid antibodies in, 775 cancer in, 795 cardiovascular disease in, 794 clinical presentation of, diagnostic criteria for, emergencies in, epidemiology of, 768 in pregnancy, 775 kidney disease in, 794 monitoring of, 773 osteoporosis in, 794 physician-patient interaction in, 771 treatment of, , T Tacrolimus, monitoring of, Temporal arteritis, classification of, 762 clinical presentation of, course of, 765 diagnosis of, differential diagnosis of, 762 epidemiology of, 757 pathogenesis of, 758 treatment of, Tender points, in fibromyalgia, 744, Tenosynovitis, in temporal arteritis, 760 Tetracycline, for reactive arthritis, 715 Thrombosis in SLE, 775 in temporal arteritis, 758 Tongue, necrosis of, in temporal arteritis, 759 Tophi, in gout, 704 Tramadol for fibromyalgia, Transcranial direct current stimulation, for fibromyalgia, 753

11 Index 815 Triamcinolone, for gout, Tricyclic antidepressants, Tuberculosis in DMARD use, 799 in rheumatoid arthritis, 790 Tumor necrosis factor-a inhibitors, monitoring of, 799 U Ultrasonography, for temporal arteritis, 761 Uric acid in gout, measurement of, 678, 684, 717 V Vancomycin, for infectious arthritis, 720 Vasculitis, of temporal arteries. See Temporal arteritis. Venlafaxine, for fibromyalgia, 750 Viral arthritis, treatment of, 719 Viscosity, of synovial fluid, 693 Visual loss, in temporal arteritis, 759, 763 W Warfarin, for antiphospholipid antibody syndrome, in SLE, 775 Z Zolpidem, for fibromyalgia, 750 Zopiclone, for fibromyalgia, 750

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases

More information

Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition

Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition Firestein, G ISBN-13: 9781437717389 Table of Contents VOLUME I STRUCTURE AND FUNCTION OF BONE,

More information

Arthritis. that affects the joints.

Arthritis. that affects the joints. Arthritis that affects the joints. The word arthritis literally means inflammation of the joints. Though joint inflammation is often a symptom, rather than a specific diagnosis itself, the term arthritis

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abatacept, 239 Acetaminophen, 194 Acupuncture, 205 Adalimumab, 187, 226, 239, 247 Allopurinol, for gout, 188 American College of Rheumatology,

More information

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour Patient #1 Rheumatoid Arthritis Essentials For The Family Medicine Physician 45 y/o female Morning stiffness in her joints >1 hour Hands, Wrists, Knees, Ankles, Feet Polyarticular, symmetrical swelling

More information

Rheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.

Rheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center. Rheumatology Review Update in Internal Medicine Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston MA Case #1 True statement(s) regarding etanercept and leflunomide, for the treatment

More information

Rheumatoid arthritis

Rheumatoid arthritis Rheumatoid arthritis 1 Definition Rheumatoid arthritis is one of the most common inflammatory disorders affecting the population worldwide. It is a systemic inflammatory disease which affects not only

More information

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT Essential Rheumatology Dr Ellen Bruce Consultant Rheumatologist CMFT Saving the best for last! Apparently people recall best the first and last thing they re told. Far too difficult to include everything.

More information

Rheumatology Cases for the Internist

Rheumatology Cases for the Internist Rheumatology Cases for the Internist Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine University of Maryland School

More information

Rheumatoid Arthritis

Rheumatoid Arthritis Rheumatoid Arthritis What is rheumatoid arthritis? Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Rheumatoid arthritis can also cause inflammation of

More information

Table 61-5: Normal Physical Assessment of the Musculoskeletal System, p Table 61-1: Gerontologic Assessment Differences, p1451

Table 61-5: Normal Physical Assessment of the Musculoskeletal System, p Table 61-1: Gerontologic Assessment Differences, p1451 Unit II: Activity and Rest Needs- Musculoskeletal System Los Angeles Harbor College Associate Degree Nursing Program Description: After appropriate study and practice, the nursing student will be able

More information

Coverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication

Coverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Kineret (anakinra subcutaneous injection) Commercial HMO/PPO/CDHP

More information

The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy

The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy Learning Objectives When to use an acute rheumatology service Appropriate use of steroids by condition Injection or Oral or Intramuscular

More information

Osteoarthritis. Rheumatology Update. Gout 1/17/2013

Osteoarthritis. Rheumatology Update. Gout 1/17/2013 Osteoarthritis Rheumatology Update Richard Zweig, MD January, 2013 Degeneration of cartilage over time accompanied by increase in bone density and bone formation around the joint Risks include: aging,

More information

Medical Management of Rheumatoid Arthritis (RA)

Medical Management of Rheumatoid Arthritis (RA) Medical Management of Rheumatoid Arthritis (RA) Dr Lee-Suan Teh Rheumatologist Royal Blackburn Hospital Educational objectives ABC Appreciate the epidemiology of RA Be able to diagnosis of RA Competent

More information

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010 Objectives Rheumatology for the Primary MD (Not just your grandmother s disease) Identify when it is appropriate to refer for rheumatologic evaluation Autoimmune/ Inflammatory v. noninflammatory disease

More information

TABLE OF CONTENTS. Contents

TABLE OF CONTENTS. Contents TABLE OF CONTENTS Contents TABLE OF CONTENTS This media guide was created by the American College of Rheumatology and is designed to be used as a reference by members of the media who are reporting on

More information

Rheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011

Rheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011 Rheumatoid Arthritis Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011 The security of experience. The power of innovation. www.rgare.com Case Study

More information

Step Therapy Approval Criteria

Step Therapy Approval Criteria Effective Date: 10/01/2016 This document contains Step Therapy Approval Criteria for the following medications: 1. Colcrys (colchicine) 2. Cymbalta (duloxetine) 3. Dovonex (calcipotriene) 4. Enbrel (etanercept)

More information

Salicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 &

Salicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 & DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS Chapters 17, 18, 34 & Pages 577 & 579-586 Salicylates aspirin Have analgesic, antipyretic, and anti-inflammatory effects. Inhibits the production

More information

Rheumatologic Laboratory Testing and Common Hematological Drugs. September 10, 2013 Dr. Jeffrey C. Hoschek, MD, FAAP

Rheumatologic Laboratory Testing and Common Hematological Drugs. September 10, 2013 Dr. Jeffrey C. Hoschek, MD, FAAP Rheumatologic Laboratory Testing and Common Hematological Drugs September 10, 2013 Dr. Jeffrey C. Hoschek, MD, FAAP THERE ARE MULTIPLE TESTS USED TO BOTH SCREEN FOR AND MAKE THE DIAGNOSIS OF MANY RHEUMATOLOGICAL

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abuse, child, 255 Activities of daily living, energy conservation in, 385 Acupuncture, 400 401 Adrenergic receptors, in pain generation, 286

More information

Introduction. Rheumatoid Arthritis. Rheumatoid Arthritis. Arthritis vs Rheumatoid Arthritis

Introduction. Rheumatoid Arthritis. Rheumatoid Arthritis. Arthritis vs Rheumatoid Arthritis Rheumatoid Arthritis Stuart Weisman, MD Boulder Medical Center, P.C. 303-622-3724 Introduction What is rheumatoid arthritis? How is it different than arthritis? What are the symptoms? How is it diagnosed?

More information

Rheumatology Updates for the Primary Care Provider

Rheumatology Updates for the Primary Care Provider Rheumatology Updates for the Primary Care Provider Jean Tayar, MD, RhMSUS Associate Professor Section of Rheumatology and Clinical Immunology Department of General Internal Medicine UT MD Anderson Cancer

More information

Seronegative Arthritis. Dr Mary Gayed 25 th April 2018

Seronegative Arthritis. Dr Mary Gayed 25 th April 2018 Seronegative Arthritis Dr Mary Gayed 25 th April 2018 Overview Description of the conditions Discussion of symptoms & investigations that may be required Discussion of management and treatment Questions

More information

REFERRAL GUIDELINES: RHEUMATOLOGY

REFERRAL GUIDELINES: RHEUMATOLOGY Outpatient Page 1 1 REFERRAL GUIDELINES: RHEUMATOLOGY Date of birth Demographic Contact details (including mobile phone) Clinical Reason for referral Duration of symptoms Essential Referral Content Referring

More information

Rheumatoid Arthritis. By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University

Rheumatoid Arthritis. By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University Rheumatoid Arthritis By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University Introduction RA is a Chronic, Systemic, Inflammatory disorder of unknown etiology

More information

Rheumatology Objec1ves. Rheumatology Objec1ves By the end of this presenta1on, the a<endee should be able to: 5/5/11

Rheumatology Objec1ves. Rheumatology Objec1ves By the end of this presenta1on, the a<endee should be able to: 5/5/11 April 29, 2011 Presented by: Elizabeth M. Etherton, MSN, ACNP- BC, CNP Rheumatology Specialty Clinic University of New Mexico Health Science Center Rheumatology Objec1ves By the end of this presenta1on,

More information

Manifestations and Presentations of Collagen Vascular Diseases. Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL

Manifestations and Presentations of Collagen Vascular Diseases. Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL Manifestations and Presentations of Collagen Vascular Diseases Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL June 29, 2018 Disclosures Joseph LaConti, M.D., Ph.D., has

More information

Learning Objectives and Assessment Methodologies Combined Medicine-Pediatrics Rheumatology Elective

Learning Objectives and Assessment Methodologies Combined Medicine-Pediatrics Rheumatology Elective Learning Objectives and Assessment Methodologies Combined Medicine-Pediatrics Rheumatology Elective Overview: Med-Peds PGY2 s, PGY3 s and PGY4 s can elect to spend one four-week rotation with the adult

More information

Biologics for Autoimmune Diseases

Biologics for Autoimmune Diseases Biologics for Autoimmune Diseases Goal(s): Restrict use of biologics to OHP funded conditions and according to OHP guidelines for use. Promote use that is consistent with national clinical practice guidelines

More information

Helpline No:

Helpline No: ARTHRITIS FOUNDATION Registered Nonprofit Organisation - No. 002-847 NPO Helpline No: 0861 30 30 30 DRUGS AND ARTHRITIS This information leaflet is published by the Arthritis Foundation as part of our

More information

Scleritis LEN V KOH OD

Scleritis LEN V KOH OD Scleritis LEN V KOH OD 2014 PUCO 1 Introduction A painful, destructive, and potentially blinding disorder Highly symptomatic High association with systemic disease Immunosuppresssive agents 2014 PUCO 2

More information

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis. LENGTH OF AUTHORIZATION: Initial: 3 months for Crohn s or Ulcerative Colitis; 1 year for all other indications. Renewal: 1 year dependent upon medical records supporting response to therapy and review

More information

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type. Prim Care Clin Office Pract 31 (2004) 441 447 Index Note: Page numbers of article titles are in boldface type. A Abscess, brain, headache in, 388 Acetaminophen for migraine, 406 407 headache from, 369

More information

Pain or stiffness in joints after periods of inactivity or excessive use

Pain or stiffness in joints after periods of inactivity or excessive use Arthritis Awareness* Some older adults call it Arthur ; others refer to it as their constant compassion, but most describe it as extremely painful Arthritis is a chronic joint disease It is commonly believed

More information

CIMZIA (certolizumab pegol)

CIMZIA (certolizumab pegol) Pre - PA Allowance None Prior-Approval Requirements Age Diagnoses 18 years of age or older Patient must have ONE of the following: 1. Moderate to severe Crohn s Disease (CD) a. Inadequate response, intolerance

More information

ACP Rheumatology Pearls. Adam Q Carlson MD Assistant Professor UVA Rheumatology

ACP Rheumatology Pearls. Adam Q Carlson MD Assistant Professor UVA Rheumatology ACP Rheumatology Pearls Adam Q Carlson MD Assistant Professor UVA Rheumatology Disclosures I have no personal or professional disclosures Case #1 27 yo woman with a history of systemic lupus complicated

More information

Headaches, 37, 42 Hypnotherapy, 101t, 106 Hypothalamic-pituitary-adrenal (HPA) axis, 59, 61, 63, 64, 65

Headaches, 37, 42 Hypnotherapy, 101t, 106 Hypothalamic-pituitary-adrenal (HPA) axis, 59, 61, 63, 64, 65 INDEX Note: page numbers in italic typeface indicate figures. Page numbers followed by a t indicate tables. Abbreviations are for terms listed on pages 135-137. Acetaminophen/tramadol in fibromyalgia,

More information

Cimzia. Cimzia (certolizumab pegol) Description

Cimzia. Cimzia (certolizumab pegol) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.11 Section: Prescription Drugs Effective Date: April 1, 2018 Subject: Cimzia Page: 1 of 5 Last Review

More information

The diagnostic challenge of joint pain part 2

The diagnostic challenge of joint pain part 2 Musculoskeletal 407 The diagnostic challenge of joint pain part 2 Polyarthralgia is a common presentation in primary care. Because chronic arthritides may present abruptly, they need to be considered in

More information

Scintigraphic Findings and Serum Matrix Metalloproteinase 3 and Vascular Endothelial Growth Factor Levels in Patients with Polymyalgia Rheumatica

Scintigraphic Findings and Serum Matrix Metalloproteinase 3 and Vascular Endothelial Growth Factor Levels in Patients with Polymyalgia Rheumatica The Open General and Internal Medicine Journal, 29, 3, 53-57 53 Open Access Scintigraphic Findings and Serum Matrix Metalloproteinase 3 and Vascular Endothelial Growth Factor Levels in Patients with Polymyalgia

More information

A CRP B FBC C LFT D blood culture E uric acid

A CRP B FBC C LFT D blood culture E uric acid 1 A 39 year old lady with rheumatoid arthritis is admitted to hospital with a hot, swollen and painful right knee. Which is the most important blood test? A CRP B FBC C LFT D blood culture E uric acid

More information

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 1 Other Types of Lupus Discoid Lupus Erythematosus Lupus Pernio --- Sarcoidosis Lupus Vulgaris --- Tuberculosis of the face Manifestations of SLE Fever Rashes Arthritis

More information

MMS Pharmacology Lecture 2. Antirheumatic drugs. Dr Sura Al Zoubi

MMS Pharmacology Lecture 2. Antirheumatic drugs. Dr Sura Al Zoubi MMS Pharmacology Lecture 2 Antirheumatic drugs Dr Sura Al Zoubi Revision Rheumatoid Arthritis Definition (RA): is the most common systemic inflammatory disease characterized by symmetrical inflammation

More information

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 9 Last Review Date: March 16, 2018 Simponi / Simponi

More information

Differential Diagnosis And Tests Of Rheumatoid Arthritis And Its Implication For Physiotherapy

Differential Diagnosis And Tests Of Rheumatoid Arthritis And Its Implication For Physiotherapy Differential Diagnosis And Tests Of Rheumatoid Arthritis And Its Implication For Physiotherapy Onwunzo Chinelo Nkemdilim Physiotherapy Unit, General Hospital Ekwulobia, Ministry of Health, Awka, Anambra

More information

THERAPY in RHEUMATOLOGY

THERAPY in RHEUMATOLOGY THERAPY in RHEUMATOLOGY RA OA AS Systemic diseases SLE Dermatomyositis Scleroderma Gout Rheumatic fever Lyme disease RHEUMATOID ARTRHRITIS Education Build a cooperative long-term relationship Use materials

More information

Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March. (minutes for web publishing)

Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March. (minutes for web publishing) Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March 2011 (minutes for web publishing) Ad-Hoc Rheumatology Subcommittee minutes are published in accordance with the Terms of Reference for the

More information

13. Behçet s - In Children

13. Behçet s - In Children Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk 13. Behçet s - In Children How are children affected by Behçet s disease? Behçet s disease (also

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acetaminophen, in neck pain, 505 506 Acupuncture, chi and, 524 for mechanical neck disorders, 525 in neck pain, 524 525 safety of, 525 Adson

More information

Disclosures. Goals. Rheumatology Review for Primary Care. No commercial disclosures. We will be discussing non-fda approved uses for some medications.

Disclosures. Goals. Rheumatology Review for Primary Care. No commercial disclosures. We will be discussing non-fda approved uses for some medications. Rheumatology Review for Primary Care April 27, 2018 MONA Coming Together in Advanced Practice Disclosures No commercial disclosures. We will be discussing non-fda approved uses for some medications. Goals

More information

Rheumatology Primer: What Labs and When

Rheumatology Primer: What Labs and When Rheumatology Primer: What Labs and When Irina Konon, MD Department of Internal Medicine Division of Rheumatology Medical College of Wisconsin Disclosures None 1 Objective Discuss principles of laboratory

More information

(minutes for web publishing)

(minutes for web publishing) Rheumatology Subcommittee of the Pharmacology and Therapeutics Advisory Committee (PTAC) Meeting held on 17 October 2017 (minutes for web publishing) Rheumatology Subcommittee minutes are published in

More information

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he LIVING WITH SYSTEMIC LUPUS ERYTHEMATOSUS Stacy Kennedy, M.D.,M.B.A. Rowan Diagnostic Clinic Salisbury, N.C. May 11, 2013 Agenda What is lupus Who is affected Causes of lupus Symptoms and organ involvement

More information

Rheumatologic Emergencies It s not just swollen joints. Joanne Homik Rheumatologist University of Alberta

Rheumatologic Emergencies It s not just swollen joints. Joanne Homik Rheumatologist University of Alberta Rheumatologic Emergencies It s not just swollen joints Joanne Homik Rheumatologist University of Alberta Or is it? Disclosures No relevant conflicts of interest regarding the content of this presentation

More information

2. Has the patient had a response to treatment? Y N. 3. Does the patient have a diagnosis of rheumatoid arthritis (RA)? Y N

2. Has the patient had a response to treatment? Y N. 3. Does the patient have a diagnosis of rheumatoid arthritis (RA)? Y N 12/21/2016 Prior Authorization Aetna Better Health of West Virginia Humira (WV88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and

More information

Pharmacy Prior Authorization

Pharmacy Prior Authorization Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,

More information

Immune Modulating Drugs Prior Authorization Request Form

Immune Modulating Drugs Prior Authorization Request Form Patient: HPHC member ID #: Requesting provider: Phone: Servicing provider: Diagnosis: Contact for questions (name and phone #): Projected start and end date for requested Requesting provider NPI: Fax:

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Osteoarthritis Osteoarthritis is the most common type of joint disease. It represents a group of conditions that result in changes

More information

Pharmacy Prior Authorization

Pharmacy Prior Authorization Pharmacy Prior Authorization MERC CARE PLA (MEDICAID) Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax

More information

FIBROMYALGIA. Howard L. Feinberg, D.O. F.A.C.O.I., F.A.C.R. OPSC San Diego 2017

FIBROMYALGIA. Howard L. Feinberg, D.O. F.A.C.O.I., F.A.C.R. OPSC San Diego 2017 FIBROMYALGIA Howard L. Feinberg, D.O. F.A.C.O.I., F.A.C.R. OPSC San Diego 2017 Sir William Osler When a patient with arthritis comes in the front door, I try to go out the back door. FEINBERG S COROLLARY

More information

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus? Lupus Systemic lupus erythematosus, referred to as SLE or lupus, is sometimes called the "great imitator." Why? Because of its wide range of symptoms, people often confuse lupus with other health problems.

More information

Rheumatology Residency Rotation University of Colorado Health Sciences Center

Rheumatology Residency Rotation University of Colorado Health Sciences Center 2010 Rheumatology Residency Rotation University of Colorado Health Sciences Center This paragraph only applies if you are rotating at the University of Colorado Hospital. Please review the rest of the

More information

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS LUPUS 101 LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS SLE SUBSETS SUBACUTE CUTANEOUS LUPUS DRUG INDUCED LUPUS NEONATAL LUPUS LATE ONSET LUPUS ANTI-PHOSPHOLIPID

More information

Inflammatory rheumatic diseases

Inflammatory rheumatic diseases Learning objectives Inflammatory rheumatic diseases Bruce Kidd Barts & The London, Queen Mary, University of London To understand: 1. prevalence and range of the rheumatological s 2. clinical features

More information

Rheumatology Potpourri. Dr. Philip A. Baer Seacourses Asia CME December 2017

Rheumatology Potpourri. Dr. Philip A. Baer Seacourses Asia CME December 2017 Rheumatology Potpourri Dr. Philip A. Baer Seacourses Asia CME December 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted

More information

ACTEMRA (tocilizumab)

ACTEMRA (tocilizumab) Pre - PA Allowance None Prior-Approval Requirements Diagnoses Patient must have ONE of the following: 1. Active Polyarticular Juvenile Idiopathic Arthritis (PJIA) b. Patient has an intolerance or has experienced

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acetaminophen in chronic pain management, 225 Acupuncture in chronic pain management, 251, 338 339 Ajurvedic medicine in chronic pain management,

More information

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda) Pre - PA Allowance None Prior-Approval Requirements Diagnoses Patient must have ONE of the following: 6 years of age or older 1. Moderate to severe Crohn s disease (CD) a. Patient has fistulizing disease

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 28 Effective Health Care Program Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) Executive Summary Background

More information

First Presentation of Joint Pain

First Presentation of Joint Pain First Presentation of Joint Pain Andrew Harrison Rheumatologist Wellington Regional Rheumatology Unit, HVDHB Bowen Centre, Crofton Downs, Wellington Assoc. Prof. in Medicine, University of Otago Wellington

More information

Analgesics. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014

Analgesics. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014 Analgesics Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014 Mar-14 Munir Gharaibeh, MD, PhD, MHPE 2 Feature Comparison of Analgesics Narcotic (Opioids) Nonnarcotic

More information

Subject: Remicade (Page 1 of 5)

Subject: Remicade (Page 1 of 5) Subject: Remicade (Page 1 of 5) Objective: I. To ensure that Health Share/Tuality Health Alliance (THA) has a process by which the appropriate utilization of Remicade (Infliximab) for members whose diagnosis

More information

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases Line of Business: Medicaid P & T Approval Date: August 16, 2017 Effective Date: August 16, 2017 This policy

More information

Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z

Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z Topic Page: Systemic Lupus Erythematosus Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z What Is It? Lupus is thought to develop when the immune system

More information

Clinical Trials in Rheumatology

Clinical Trials in Rheumatology Clinical Trials in Rheumatology Rüdiger Müller Johannes von Kempis Clinical Trials in Rheumatology Authors Rüdiger Müller Division of Rheumatology and Rehabilitation Department of Internal Medicine Kantonsspital

More information

4 2 Osteoarthritis 1

4 2 Osteoarthritis 1 Osteoarthritis 1 Osteoarthritis ( OA) Osteoarthritis is a chronic disease and the most common of all rheumatological disorders. It particularly affects individuals over the age of 65 years. The prevalence

More information

Cimzia. Cimzia (certolizumab pegol) Description

Cimzia. Cimzia (certolizumab pegol) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Cimzia Page: 1 of 5 Last Review Date: March 17, 2017 Cimzia Description Cimzia (certolizumab pegol)

More information

Course instructors (2 hour lecture) 1. Barbara Caffery OD, PhD, FAAO Diplomate, Cornea, Contact Lenses, and Refractive Technologies

Course instructors (2 hour lecture) 1. Barbara Caffery OD, PhD, FAAO Diplomate, Cornea, Contact Lenses, and Refractive Technologies Course instructors (2 hour lecture) 1. Barbara Caffery OD, PhD, FAAO Diplomate, Cornea, Contact Lenses, and Refractive Technologies 2. Danielle Robertson, OD, PhD, FAAO, FBCLA Diplomate, Cornea, Contact

More information

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS Stacy Kennedy, M.D.,M.B.A. October 20, 2012 Agenda What is lupus Who is affected Causes of lupus Symptoms and organ involvement Diagnosis Treatment Pregnancy

More information

Benlysta (belimumab) Prior Authorization Criteria Program Summary

Benlysta (belimumab) Prior Authorization Criteria Program Summary Benlysta (belimumab) Prior Authorization Criteria Program Summary This prior authorization applies to Commercial, NetResults A series, NetResults F series and Health Insurance Marketplace formularies.

More information

Cosentyx. Cosentyx (secukinumab) Description

Cosentyx. Cosentyx (secukinumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.11 Subject: Cosentyx Page: 1 of 7 Last Review Date: September 20, 2018 Cosentyx Description Cosentyx

More information

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018. What is giant cell arteritis (GCA)? Giant cell arteritis (GCA) is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage

More information

Rheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy

Rheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy Rheumatoid arthritis, seronegative spondylarthritides and gout György Nagy Dec 4, 2017 Rheumatoid arthritis Rheumatoid arthritis Chronic, progressive, autoimmune disorder of the joints with extra-articular

More information

Learning about Lupus. Learning About Lupus. Lupus Society of Illinois

Learning about Lupus. Learning About Lupus. Lupus Society of Illinois Learning About Lupus Learning about Lupus Lupus Society of Illinois 525 W. Monroe Street, Suite 900 Chicago, Illinois 60661 Robert S. Katz, M.D. Professor of Medicine Rush University Medical Center Northwestern

More information

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA 24800 HUMIRA PEDIATRIC GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Is the patient currently taking Humira? If

More information

Case Report Pseudoseptic Arthritis: A Case Series and Review of the Literature

Case Report Pseudoseptic Arthritis: A Case Series and Review of the Literature Case Reports in Infectious Diseases Volume 2011, Article ID 942023, 4 pages doi:10.1155/2011/942023 Case Report Pseudoseptic Arthritis: A Case Series and Review of the Literature Brian P. Oppermann, 1

More information

Is it Autoimmune or NOT! Presented to AONP! October 2015!

Is it Autoimmune or NOT! Presented to AONP! October 2015! Is it Autoimmune or NOT! Presented to AONP! October 2015! Four main jobs of immune system Detects Contains and eliminates Self regulates Protects Innate Immune System! Epithelial cells, phagocytic cells

More information

Understanding Rheumatoid Arthritis

Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result

More information

9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service

9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service Temporal Arteritis Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service 1 Background Giant Cell Arteritis Temporal Arteritis Cranial Arteritis Granulomatous Arteritis

More information

HAQ-II(Health Assessment Questionnaire-II)

HAQ-II(Health Assessment Questionnaire-II) Kathy Karamlou, MD 355 Placentia Ave, suite 208 Newport Beach, CA 92663 949-631-6500 949-631-9700 NAME: DATE: DOB: HAQ-II(Health Assessment Questionnaire-II) We are interested in learning how your illness

More information

Otezla. Otezla (apremilast) Description

Otezla. Otezla (apremilast) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Otezla Page: 1 of 5 Last Review Date: March 16, 2018 Otezla Description Otezla (apremilast) Background

More information

Regulatory Status FDA-approved indication: Orencia is a selective T cell co-stimulation modulator indicated for: (1)

Regulatory Status FDA-approved indication: Orencia is a selective T cell co-stimulation modulator indicated for: (1) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Orencia Page: 1 of 9 Last Review Date: September 20, 2018 Orencia Description Orencia (abatacept)

More information

Polymyalgia rheumatica and giant cell arteritis

Polymyalgia rheumatica and giant cell arteritis Polymyalgia rheumatica and giant cell arteritis What is polymyalgia rheumatica? Polymyalgia rheumatica is a rheumatic disorder associated with moderate-to-severe musculoskeletal pain and stiffness in the

More information

Rheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology

Rheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Eugene Rheumatology Financial Relationships Amgen Genentech AbbVie IS THIS LUPUS? S.T. is a 45 y/o woman with 9 months of joint pain, fatigue,

More information

Remicade (infliximab) DRUG.00002

Remicade (infliximab) DRUG.00002 Applicability/Effective Date *- Florida Healthy Kids Remicade (infliximab) DRUG.00002 Override(s) Prior Authorization Step Therapy Medications Remicade (infliximab) Approval Duration 1 year Comment Intravenous

More information

Birthdate: / / Address: Age: Sex: M F. Telephone: H ( ) City State Zip W ( ) C ( )

Birthdate: / / Address: Age: Sex: M F. Telephone: H ( ) City State Zip W ( ) C ( ) Please complete this questionnaire in its entirety, even if you feel some questions may not apply to you. Our staff is available should you have any questions, or need assistance with the completion of

More information